# Biological Therapy in Treating Patients With Metastatic Cancer

> **NCT00004604** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 24 (actual)

## Conditions studied

- Breast Cancer
- Colorectal Cancer
- Extrahepatic Bile Duct Cancer
- Gallbladder Cancer
- Gastric Cancer
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Metastatic Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Testicular Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** CEA RNA-pulsed DC cancer vaccine

## Key facts

- **NCT ID:** NCT00004604
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-02
- **Primary completion:** 2001-06
- **Final completion:** 2002-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004604, "Biological Therapy in Treating Patients With Metastatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00004604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*